Loss-of-function mutations in AMH and AMHR2 have been identified in PCOS patients, which could result in dysregulation of enzymes involved in the synthesis of testosterone, leading to a hyperandrogenic state. This evidence concerns the gene AMH and polycystic ovary syndrome.